This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: How to Value a Stock

When asked about the company's finances, Lanphier said Sangamo is cash-flow positive and is very well financed thanks to its strong partnerships.

Lanphier continued that Sangamo's platform will allow for many treatments to be developed, which is why the company plans for an additional four programs to be trials before the end of the year.

Cramer said that while speculative, Sangamo is still an exciting story, and one than can cure a lot of diseases if it's successful.

Executive Decision: Michael Ward

In his second "Executive Decision" segment, Cramer sat down with Michael Ward, chairman, president and CEO of railroad CSX (CSX - Get Report).

Ward painted a very optimistic picture for CSX in 2014. He said that even with $800 million of coal volume lost in the last two years, CSX has still been able to grow its other businesses faster than the decline.

One of those other businesses included intermodal cargo, where CSX ships 3.7 million containers a year. Ward said with another nine million containers still out there, the room for growth is significant.

Other positives for CSX included a renaissance in chemicals thanks to cheap natural gas, increased oil production in the Bakken shale and a pickup in autos and housing.

Yet, throughout all its growth, CSX still maintained the title of safest railroad in the U.S. Cramer said he's still a big believer in CSX.

Lightning Round

In the Lightning Round, Cramer was bullish on DuPont (DD), Whole Foods Markets (WFM), Lockheed Martin (LMT) and Huntington Ingalls (HII).

Cramer was bearish on GT Advanced Technologies (GTAT), SunEdison (SUNE) and Incyte (INCY).

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CSX $34.79 -0.88%
PF $42.67 -0.37%
SGMO $12.15 -0.82%
AAPL $131.70 -0.26%
FB $80.36 -0.24%

Markets

DOW 18,121.49 -41.50 -0.23%
S&P 500 2,120.22 -3.26 -0.15%
NASDAQ 5,096.4520 -10.1410 -0.20%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs